Abstract: Disclosed are blow molded automotive articles comprising a coupled propylene polymer composition.

Abstract: An emulsion polymerization process for the preparation of polybutadiene grafted with styrene and acrylonitrile monomers in a reaction system is provided. The resultant product has a low end content of unreacted residual monomers, low yellowness index, and improved impact strength. The diene rubber is prepared via a process wherein a chain transfer agent is added on a continuous basis to give a rubber substrate having a low crosslink density. In one embodiment of the invention, the process includes charging the reaction system with a pre-selected diene emulsion with a low crosslink density, adding a first portion of at least one of a styrene monomer and acrylonitrile monomer to the diene emulsion, adding to the reaction system, over a predetermined time, an initiator and a second portion of acrylonitrile and styrene monomer, and polymerizing the catalyzed reaction mixture of diene substrate, styrene and acrylonitrile to form ABS graft polymers.

Abstract: The invention relates to a method for removing bile salts from a patient in need thereof and compositions useful in the method. The method comprises administering to the patient a therapeutically effective amount of a salt of an alkylated and crosslinked polymer. The alkylated and crosslinked polymer salt comprises the reaction product of crosslinked polymers, or salts and copolymers thereof having amine containing repeat units, with at least one aliphatic alkylating agent.

Abstract: This invention relates to a rubber composition for extrusion and molding comprising 100 weight parts of ethylene/&agr;-olefin/non-conjugated polyene copolymer (A) composed of ethylene, &agr;-olefin having carbon atoms of 3-20 and non-conjugated polyene, and at least 30-300 weight parts of carbon black (B), and 1.0×10−5-5.0×10−3 mol of an alkoxysilane compound shown by the following formula (I): wherein, R is alkyl or alkoxy, R1 is alkyl or phenyl, n is 0, 1 or 2, R2 is a bivalent hydrocarbon, R3 is arylene group, m and p are 0 or 1 respectively, and m and p are not 0 at a same time, q is 1 or 2, and D is —SCN or —SH when q is 1, and —Sx— when q is 2 (wherein x is an integer of 2-8).

Abstract: A controlled free-radical polymerization process for forming end-functionalized polymers is disclosed, particularly by degenerative iodine transfer. The end-functionalized polymers are characterized by a polydispersity less than 2.5 and a predetermined molecular weight. The end-functionalized polymers are useful as reactive intermediates in condensation polymerization, chain polymerization and heterogeneous polymerization reactions.

Abstract: The present invention relates to an antistatic polymer composition and more specifically to a composition comprising a thermoplastic polymer (A) and a copolymer (B) comprising polyamide blocks and polyether blocks comprising essentially ethylene oxide units —(C2H4—O)—, the copolymer (B) having a melting temperature of between 80 and 150° C. It is of use for the polymers (A) which are heat-sensitive or which are processed at low temperature.

Abstract: A crosslinking agent is provided, prepared by reacting (A) an aminoplast resin; (B) a reactive urethane group-containing adduct and (C) at least one other compound having active hydrogen groups reactive with aminoplast resin (A). Compound (C) is selected from: (i) compounds having the structure (I):  wherein X is aromatic; R1, R2, and R3 each independently represents H, (cyclo)alkyl having from 1 to 12 carbon atoms, aryl, alkaryl, aralkyl, or an active hydrogen-containing group, (ii) compounds having the structure (II) or (III):  where R′ and R″ each independently represents an aromatic group or an alkyl group having 1 to 12 carbon atoms; and (iii) compounds different from (i) and (ii), having a melting point of at least 80° C. Further provided are methods for preparing the crosslinking agent curable compositions containing the crosslinking agent, and coated substrates.

Abstract: A prepolymer, represented by the formula: wherein n is an average value grater than or equal to 0, Ar is an aromatic group, and each R10 is independently selected from the group consisting of alkyl, aryl, alkylaryl, haloalkyl, haloaryl and mixtures thereof and each R11 is independently selected from the group consisting of alkyl, aryl, alkylaryl, haloalkyl, haloaryl and mixtures thereof.

Abstract: A powder coating composition comprises at least one thermosetting resin such as epoxy resins, carboxy- or hydroxy-functional polyesters; hydroxy-, carboxyl- or glycidyl-functional acrylic resins; and/or hydroxy- or carboxyl-functional fluoropolymers, fluorochloropolymers or fluoroacrylic polymers blended with a at least one poly(phenylene ether) and at least one curing agent for the thermosetting resin.

Abstract: The present invention relates to catalyst system containing at least one imidochrome compound and at least one activation compound. This invention also relates to imidochrome compounds, to a method for olefin polymerization and to methods for producing said imidochrome compounds.

Abstract: Processes for chemically-modifying the surface of an emulsion polymer particle are provided which include providing an aqueous emulsion polymer, a monomer at a level of at least 0.5% by weight based on the weight of the emulsion polymer and a, surface-modifying chemical capable of bonding with the monomer, under conditions where there is no substantial polymerization of the monomer, and then reducing the level of the monomer by at least 50%.

Abstract: A solid catalyst component comprises a transition metal-containing metallocene compound, a non-cyclopentadienyl transition metal compound, a magnesium compound and a polymeric material which acts as a support. The catalyst component is combined with co-catalyst organoaluminum compound or a mixture of organoaluminum compounds to provide a catalyst composition useful for olefin polymerization, e.g., to produce linear low, medium and high density polyethylenes or copolymerization of ethylene with alpha-olefins. Product polyolefin polymers have a varied range of molecular weight distributions. The catalyst composition is prepared by a process comprising combining polymer support particles, magnesium compound, transition metal-containing metallocene compound, and non-cyclopentadienyl transition metal compound to provide a solid catalyst component, and, combining the solid catalyst component with a cocatalyst compound to provide a polyolefin polymerization catalyst composition.

Abstract: Initiators for nitroxide-mediated radical polymerizations are described. The initiators have an azlactone or ring-opened azlactone moiety to provide telechelic (co)polymers.

Abstract: Initiators for nitroxide-mediated radical polymerizations are described. The initiators have an azlactone or ring-opened azlactone moiety to provide telechelic (co)polymers.

Abstract: The present invention relates to a process for preparing copolymer hydrogels with controlled molecular weights and having both thermo- and pH-responsive properties, wherein the process comprises the steps of (a) providing sulfonamide type styrenic or (meth)acrylamide-based monomers exhibiting different pKa values; (b) providing poly(N-isopropylacrylamide) or crosslinked poly(N-isopropylacrylamide-co-methylene bisacrylamide) hydrogels having thermo-responsive properties; and (c) providing several hydrogels exhibiting pH-sensitive properties and random or block copolymerizations of the sulfonamide type styrenic or (meth)acrylamide-based monomers prepared in step (a) with N-isopropylacrylamide and/or methylene bisacrylamide monomers used in step (b) in a polar or non-polar solvent; wherein said steps (b) and (c) are carried out by controlled/living radical polymerization using alkyl halides as the initiators and the transition metals with phosphine or amine ligands as the catalysts.

Abstract: A water-soluble, cationic polymer comprising from about 1 to about 65 mole percent of one or more cationic monomers, from about 99 to about 35 mole percent of one or more nonionic monomers and from about 1 to about 1000 ppm, based on the total monomer content, of one or more hyperbranched monomers wherein the hyperbranched monomer contains from about 2 to about 20 allyl, vinyl, or acrylic end groups and method of dewatering sludge is disclosed.

Abstract: An ether compound of formula (1) is provided wherein R1 is H or C1-6 alkyl, R2 is C1-6 alkyl, R3 is H, C1-15 acyl or C1-25 alkoxycarbonyl which may be substituted with halogen atoms, k is 0 or 1, m is from 0 to 3, and n is from 3 to 6. The ether compound is polymerized to form a polymer having improved reactivity, robustness and substrate adhesion. A resist composition comprising the polymer as a base resin is sensitive to high-energy radiation, has excellent sensitivity, resolution, and etching resistance, and lends itself to micropatterning with electron beams or deep-UV.

Abstract: This invention relates to propylene homopolymer compositions obtained from metallocene catalysis wherein the polymer has a molecular weight distribution (Mw/Mn) in the range of from 4.0 to 20.0. The propylene homopolymer composition may be prepared in a multiple stage polymerization process using the same metallocene component in at least two stages. The composition may comprise isotactic homopolymer in one embodiment, and have a hexane extractables of less than 2 wt % in one embodiment. The composition is useful in making films.

Abstract: A polymer has a repeating unit including at least one alkynyl group, at least one borate group, at least one silyl group and/or at least one siloxyl group. The polymer may be prepared by reacting a first compound having at least one alkynyl group and at least one siloxyl group and a second compound selected from boric acid, hydrocarbon borate, hydrocarbon boronic acid, and pyroboric acid. The polymer of the present invention possesses both the processability of an organic polymer and the thermal and oxidative stability of an inorganic polymer.

Abstract: A modified silicone compound having a branch polymer comprising a hydrophilic group, this compound being synthesized by performing an addition reaction between an organohydrogenpolysiloxane, and at least one compound chosen from an alkenylated polyoxyalkenylated compound, an alkenylated glycerine compound and an alkenylated sugar in the presence of a platinum catalyst or rhodium catalyst, and a cosmetic material containing this modified silicone compound.

Abstract: A metal-free, in particular tin-free, silane-terminated polyurethane which is useful in adhesives or sealant compositions is obtained by reacting at least one aliphatic secondary aminoalkylalkoxysilane of formula (Ia) R—NH—(CH2)3Si(R1)x(OR2)(3-X)  (Ia) or at least one aliphatic secondary aminoalkylalkoxysilane of formula (Ib) R—NH—CH2—CH(R1)—CH2—Si(R1)x(OR2)(3-X)  (Ib) wherein in the formulae (Ia) and (Ib), R is a linear or branched alkyl group having 1 to 18 C atoms, R1 is a methyl group, R2 is a methyl or ethyl group and x is 0 or 1, with a polyurethane prepolymer having at least one terminal isocyanate group in the absence of a metal catalyst.

Abstract: The invention is directed to a novel biomedical polyurethane based on diisocyanatae linked polyester polymer and diol components, said diol component having a uniform block-length.

Abstract: Methods for reducing the electrode impedance of implantable biosensors by coating the surface of the biosensor with a uniform hydrogel which allows unimpeded water movement around the sensor are provided. The surface coatings are compositions which are biocompatible and are capable of water uptake of at least 120% of their weight, more preferably at least 200% of their weight. Upon the uptake of water, the hydrogels used in the present invention will also swell and provide a layer of water around the electrodes to which the hydrogels are attached. The hydrogels can be prepared from (a) a diisocyanate, (b) a hydrophilic polymer which is a hydrophilic diol, a hydrophilic diamine, or a combination thereof, and optionally, (c) a chain extender.

Abstract: Disclosed is an active energy ray-curable polyimide resin composition which comprises a polymerizable polyimide resin (I) having an isocyanurate ring, an alicyclic structure, an imide ring and a (meth)acryloyl group and being capable of patterning with a dilute alkali aqueous solution.

Abstract: This invention is a highly concentrated stable solution of polyimide precursors (monomers) having a solids content ranging from about 80 to 98 percent by weight in lower aliphatic alcohols i.e. methyl and/or ethyl alcohol. The concentrated polyimide precursor solution comprises effective amounts of at least one aromatic diamine, at least one aromatic dianhydride or a lower molecular weight alkyl ester of said dianhydride, and a monofunctional endcap including monoamines, monoanhydrides and the lower alkyl esters of said monoanhydrides. These concentrated polyimide precursor solutions are particularly useful for the preparation of fibrous prepregs and composites for use in structural materials for military and civil applications.

Abstract: Unexpected corrosion of downstream sections of a dialkyl carbonate manufacturing apparatus has been traced to alkyl chloroformate impurities, which slowly decompose to yield hydrochloric acid. An improved process and apparatus for dialkyl carbonate synthesis reduce corrosion by physically removing or chemically decomposing the alkyl chloroformate impurities within the corrosion-resistant upstream sections of the apparatus.

Abstract: The use of phenols having a branched structure as terminal groups in polycarbonates, polyester carbonates and polyesters is disclosed. Also disclosed are polycarbonates, polyester carbonates and polyesters having such branched terminal groups, the process for their production and molded parts made therefrom.

Abstract: The instant invention provides an aromatic polyamide composition for molding which is of superior rigidity, strength, toughness, dimensional stability, resistance to chemicals, external surface appearance and sliding characteristics in high-humidity, high-temperature environments, which has a low coefficient of linear expansion and which is of low warpage. In a representative composition, 5 to 170 parts by weight of wollastonite of a number average length of approximately 5 &mgr;m to approximately 180 &mgr;m and a number average diameter of approximately 0.1 &mgr;m to 15.00 &mgr;m and the average aspect ratio of which is greater than 3:1 is compounded with 100 parts by weight of semi-aromatic polyamide in which the quantity of aromatic monomer in the monomer component that forms the polyamide is greater than 20 mol % and the melting point of which is greater than 280° C.

Abstract: A process for producing a polysuccinimide (co)polymer derivative which permits the reaction of a polysuccinimide (co)polymer with a Lewis base in a wide temperature range (90° to 300° C.) without using a pH-adjusting agent is provided. The process for producing a polysuccinimide (co)polymer derivative of this invention comprises reacting a polysuccinimide (co)polymer with a Lewis base by heating in the presence of a solvent having a low boiling point and high relative permittivity.

Abstract: A method of preparing a low allergic natural rubber latex which is less likely to cause allergy, comprising adding a protease having an exopeptidase activity to a natural rubber latex and aging the natural rubber latex, thereby to decompose a protein in the latex to such a degree that the protein and a protein decomposition product, which have a number-average molecular weight of 4500 or more, are not detected; a method of preparing a deproteinized natural rubber latex which is less likely to cause allergy, comprising adding an alkali protease to a natural rubber latex, thereby to decompose a protein in the latex, adding a protease having an exopeptidase activity, thereby to further decompose the protein and a decomposition product thereof in the latex, and removing the protein and the decomposition product thereof; a low allergic natural rubber obtained by a decomposition treatment of a protein, wherein the protein and a protein decomposition product, which have a number-average molecular weight of 4500 or m

Abstract: A method for modifying the surface properties of tissue in vivo is described. The method comprises forming a liquid crystalline matrix on the tissue surface wherein the matrix comprises a tissue surface component. In one embodiment there is provided a method for improving the bonding of surgical glues and cements to cartilage and other synovial fluid wetted tissue surfaces. Such surfaces are contacted with a composition comprising a poly(hydroxy substituted amino acid) to form a liquid crystalline matrix on the tissue surface. The matrix is readily removed to provide a tissue surface that exhibits improved bonding with surgical glues.

Abstract: N- and C-modified linear cationic peptides having antibiotic activity are disclosed, which peptides are particularly active against gram positive bacteria.

Abstract: Three genes encoding secretory membrane proteins have been successfully isolated from an osteoblast-like cell line by a method for specifically cloning secretory membrane proteins. One of these genes encodes a novel receptor protein. The protein has only the extracellular region, binds to the cell membrane via a GPI anchor, and carries therein a cysteine-rich, repetitive region commonly conserved in the TNF receptor super family. Overexpression of this protein in osteoblast-like cell line cells suppresses cell proliferation, changes cell morphology, and increases alkaline phosphatase activity, which is one of markers for differentiation of osteoblasts.

Abstract: A 2.4 Å crystal structure of a protein construct containing the catalytic kinase domain of vascular endothelial growth factor receptor 2 (VEGFR2/KDR), a key enzyme in angiogenesis, has been determined in an unliganded, phosphorylated state. This protein construct, contains a modified catalytic linker and has comparable in vitro kinase activity to constructs containing the entire KID. The resulting construct retains comparable in vitro kinase activity to that of the wild-type KID, and more importantly, allows complete crystallization of the protein such that it may be characterized by X-ray crystallography. The present invention further discloses the use of x-ray crystallographic data for identification and construction of possible therapeutic compounds in the treatment of various disease conditions.

Abstract: The invention relates to pyrazolone pigments of general formula (I), wherein the radicals R1, R2, R3 and R4 independently represent hydrogen, chlorine, methyl or ethyl, whereby at least one of the radicals R1-R4 is different from hydrogen. The inventive pigments are characterised by a CIELAB colour angle of 80-85°, a chroma of 58-62 and a luminosity ≧87 (measuring angle 45°, standard illuminant D65).

Abstract: Organic dye molecular materials prepared by coupling existing organic chromophore molecules to benzene or carbazole derivatives and nonlinear optical polymeric compounds having polyimide repeating units coupled with the organic dye molecular material are provided. The organic dye molecular material coupled to a polymer main chain in the preparation of the nonlinear optical polymeric compound has one of the following formula: where X1 is carbon, oxygen, sulfur, nitrogen, ester (CO2), or amide (CONR1), where R1 is an alky or phenyl group having 1 to 6 carbon atoms, D is an organic chromophore molecule, and n is an integer from 1 to 10.

Abstract: DNAs encoding monkey cathepsin S have been cloned and characterized. The recombinant protein is capable of forming biologically active protein. The cDNA's have been expressed in recombinant host cells that produce active recombinant protein. The recombinant protein is also purified from the recombinant host cells. In addition, the recombinant host cells are utilized to establish a method for identifying modulators of the receptor activity, and receptor modulators are identified.

Abstract: The present invention is directed to translational regulatory elements that mediate the amount of protein produced within a host capable of expressing a construct comprising one or more translational regulatory elements in operative association with a gene of interest. These translational regulatory elements were derived from T1275 (tCUP) and exhibit a high degree of similarity with members of the RENT family of repetitive elements. Translational regulatory elements are disclosed that either increase or decrease he amount of protein produced within the host organism. These translational elements are operative in a wide range of hosts including plant, animals, yeast, fungi and bacteria. Analogs, derivatives and fragments of these translational elements are also disclosed.

Abstract: Compositions and methods are provided for the modulation of ras expression. Oligonucleotides are provided which are targeted to nucleic acids encoding human ras. Oligonucleotides specifically hybridizable with mRNA encoding human H-ras, Ki-ras and N-ras are provided. Such oligonucleotides can be used for therapeutics and diagnostics as well as for research purposes. Methods are also disclosed for modulating ras gene expression in cells and tissues using the oligonucleotides provided, and for specific modulation of expression of activated ras. Methods for diagnosis, detection and treatment of conditions, or particular cancers, associated with ras are also disclosed.

Abstract: Antisense compositions targeted against an mRNA sequence coding for a selected protein, at a region having its 5′ end from 1 to about 25 base pairs downstream of a normal splice acceptor junction in the preprocessed mRNA, are disclosed. The antisense compound is RNase-inactive, and is preferably a phosphorodiamidate-linked morpholino oligonucleotide. Such targeting is effective to inhibit natural mRNA splice processing, produce splice variant mRNAs, and inhibit normal expression of the protein.

Abstract: The invention relates to a method for the preparation of compound of formula (1). The invention further relates to the previously unknown compounds of formulas (5 and 6) as intermediates in the production of benzodiazepines of formula (1).

Abstract: The present invention provides a process for the efficient assembly of Boc-protected 3-aminohydantoins/thiohydantoins and 3-aminodihydrouracils/dihydrothiouracils via a one-pot solution phase or solid phase synthesis from readily available starting materials.

Abstract: A process for making an N1-(2′-pyridyl)-1,2-alkanediamine sulfamic acid of formula II by reacting a compound of formula I with NH2R′ wherein R and R′ are as defined in the specification. The invention also includes the compound of formula II, and optical isomers thereof. The compound of formula II is an intermediate useful for making chiral piperazine derivatives which are active at the 5-HT1A receptor.

Abstract: Process for the coupling of a) nucleophiles selected from the group alcohols, thioles, amines, metallised hydrocarbons, CH-acidic compounds and metal cyanides, or of b) carbon monoxide mixed with water, alcohols, ammonia, primary or secondary amines, to organic compounds selected from the group of leaving-group-containing aromatics, hetero-aromatics with a C-bonded leaving group, aromatic or hetero-aromatic methyl compounds with a leaving group bonded to the methyl group, ethylenically unsaturated organic compounds with a C-bonded leaving group, or organic allyl compounds with a leaving group in allyl position, or c) vinyl compounds with leaving-group-containing aromatics, whilst cleaving the leaving group in the presence of Pd complexes with monophospholine ligands as the catalyst, whereby variants b) and c) are carried out in the presence of an inorganic base or organic nitrogen base, the process being characterised in that the Pd complex contains secondary monophosphines with aliphatic, branched or cycl

Abstract: The present invention provides a process for preparing a terpyridine compound of the formula I by obtaining a C1-C4-alkyl pyridine-2-carboxylate derivative by acid hydrolysis of a 2-cyanopyridine derivative by means of an anhydrous inorganic acid or its anhydride in the presence of water and a C1-C4-alkanol, with an equimolar amount of water being added to the 2-cyanopyridine derivative prior to addition of the anhydrous inorganic acid or its anhydride, subsequently condensing the resultant C1-C4-alkyl pyridine-2-carboxylate derivative with acetone in an aprotic solvent in the presence of a base, then reacting the obtained 1,5-bis(2-pyridyl)pentane-1,3,5-trione derivative with ammonia or ammonium salts (NH4)qY with removal of the water of reaction formed by employing a C1-C4-alkanol as an entrainer, and finally chlorinating the resultant 2,6-bis(2-pyridyl)-4(1H)pyridinone derivative in the presence of phosphorus oxide chloride.

Abstract: Process for the preparation of anti-ischemic and anti-hypertensive drug amlodipine besylate [2-{(2-aminoethoxy)-methyl-4-(2-chlorophenyl) 3-ethoxy carbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine} benzene sulphonate]. Phthalic anhydride is condensed with monoethanol amine at 150-190° C. The resulting N-(2-hydroxyethyl) phthalimide is coupled with 4-chloroethyl acetoacetate in the presence of sodium hydride in an organic solvent in an inert atmosphere at −11 to −15° C. Ethyl-4-[-2(phthalimido) ethoxy] acetoacetate formed is coupled with orthochloro benzaldehyde in the presence of pyridine salt at 70-90° C. Ethyl-2-(2-chloro benzylidine)4-[-2(phthalimido) ethoxy] acetoacetate fanned is condensed with methyl amino crotonate at 20-40° C.

Abstract: Hydantoin compounds which are active as glucokinase activators to increase insulin secretion which makes them useful for treating type II diabetes.

Abstract: This invention relates to a series of substituted aromatic ethers of the formula I wherein ring A and X and Y are defined as in the specification, that exhibit activity as glycine transport inhibitors, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and their use for the enhancement of cognition and the treatment of the positive and negative symptoms of schizophrenia and other psychoses in mammals, including humans.

Abstract: Disclosed is a holographic recording medium. The novel holographic recording mediums disclosed herein comprises: a) at least one polyfunctional epoxide monomer or oligomer which undergoes acid initiated cationic polymerization. Each epoxide in the monomer or oligomer is linked by group comprising a siloxane to a silicon atom and each monomer or oligomer has an epoxy equivalent weight of greater than about 300 grams/mole epoxide; b) a binder which is capable of supporting cationic polymerization; c) an acid generator capable of producing an acid upon exposure to actinic radiation; and optionally d) a sensitizer.

Abstract: Perylene derivatives of the general formula I where X and Y are independently oxygen, —NR1 or —NR2; R1 and R2 are independently hydrogen, C1-C18-alkyl, C5-C7-cycloalkyl, aryl or C1-C6-alkoxy; R3 to R10 are independently hydrogen, hydroxyl or aryl, although radicals conjointly attached to one carbon atom may also be ═O or ═CHR11, R11 is hydrogen or C1-C3-alkyl, with the proviso that said perylene derivative I contains from at least one to not more than three carbonyl groups per molecule.